US FDA greenlights nivolumab for use before surgery for NSCLC

In Brief for May 11, 2022

US FDA’s Review of Single-Country ‘Me Too’ Drugs: A Clinical Trialist Perspective

In Brief for May 25, 2022

Real-World Data from Taiwan Shows Stage Shift Has Improved Lung Cancer Survival Rates

Regulatory News for Nov. 23, 2022

In Brief for Jan. 11, 2023

In Brief for January 25, 2023

In Brief for Feb. 8, 2023

Narrow Focus Allows Pragmatica-Lung Trial to Minimize Eligibility Criteria, Significantly Reduce Data Collection, Researcher Says

Pragmatic Approach to Trial Design Born from Lung-MAP Substudy

In Brief for April 26, 2023